Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy

NCT03514368 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT03514368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03514368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2018
Completion date
November 30, 2029
Enrollment
770 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid cancers